Thomas F. Patterson

55.5k total citations · 6 hit papers
262 papers, 19.7k citations indexed

About

Thomas F. Patterson is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, Thomas F. Patterson has authored 262 papers receiving a total of 19.7k indexed citations (citations by other indexed papers that have themselves been cited), including 227 papers in Infectious Diseases, 190 papers in Epidemiology and 34 papers in Small Animals. Recurrent topics in Thomas F. Patterson's work include Antifungal resistance and susceptibility (221 papers), Fungal Infections and Studies (171 papers) and Infectious Diseases and Mycology (31 papers). Thomas F. Patterson is often cited by papers focused on Antifungal resistance and susceptibility (221 papers), Fungal Infections and Studies (171 papers) and Infectious Diseases and Mycology (31 papers). Thomas F. Patterson collaborates with scholars based in United States, United Kingdom and Canada. Thomas F. Patterson's co-authors include David W. Denning, William R. Kirkpatrick, Thomas J. Walsh, David A. Stevens, Kieren A. Marr, John R. Wingard, George R. Thompson, Raoul Herbrecht, Nathan P. Wiederhold and Dimitrios P. Kontoyiannis and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Thomas F. Patterson

262 papers receiving 19.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

2008 1.9k citations Thomas J. Walsh, David W. Denning et al. Clinical Infectious Diseases profile →
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

2002 1.9k citations John E. Bennett, David W. Denning et al. Clinical Infectious Diseases profile →
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

2016 1.8k citations Thomas F. Patterson, George R. Thompson et al. Clinical Infectious Diseases profile →
Practice Guidelines for Diseases Caused by Aspergillus

2000 581 citations David W. Denning, John E. Bennett et al. Clinical Infectious Diseases profile →
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes

2000 576 citations Thomas F. Patterson, William R. Kirkpatrick et al. profile →
Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

2017 496 citations Thomas F. Patterson et al. profile →

Peers

Countries citing papers authored by Thomas F. Patterson

Since Specialization

Citations

This map shows the geographic impact of Thomas F. Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Patterson more than expected).

Fields of papers citing papers by Thomas F. Patterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F. Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Patterson. The network helps show where Thomas F. Patterson may publish in the future.

Co-authorship network of co-authors of Thomas F. Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Patterson. A scholar is included among the top collaborators of Thomas F. Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Patterson. Thomas F. Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A case of recurrent Candida glabrata fungemia and successful treatment with rezafungin 2025 ·IDCases ·(unknown), (unknown), Gerard Gawrys, Nathan P. Wiederhold, (unknown), Thomas F. Patterson	1
2	Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis Strategies 2024 ·Open Forum Infectious Diseases ·Jo‐Anne H. Young, David R. Andes, Monica I. Ardura, Antonio Arrieta, Eric J. Bow, Pranatharthi Chandrasekar, Sharon C.‐A. Chen, Sarah P. Hammond, Shahid Husain, Sophia Koo, Valéry Lavergne, M. Hong Nguyen, Thomas F. Patterson, Miranda So, George R. Thompson, C. Orla Morrissey, Mindy G. Schuster	12
3	Olorofim demonstrates in vitro activity against Coccidioides species, including isolates against which fluconazole has reduced activity 2024 ·Antimicrobial Agents and Chemotherapy ·Nathan P. Wiederhold, Hoja Patterson, (unknown), Víctor García, George R. Thompson, Thomas F. Patterson	4
4	High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms 2023 ·Journal of Fungi ·(unknown), Gina Wall, Bruna Vidal Bonifácio, (unknown), Ashok K. Chaturvedi, Laura K. Najvar, Floyd L. Wormley, Hoja Patterson, Nathan P. Wiederhold, Thomas F. Patterson, José L. López-Ribot	7
5	Polymeric Iron Chelator with Enhanced Iron Affinity as a Broad-Spectrum Antifungal Agent 2021 ·ACS Applied Polymer Materials ·Jian Qian, Nathan P. Wiederhold, Thomas F. Patterson, Hoja Patterson, Cory Berkland	5
6	Coronavirus Disease 2019–Associated Invasive Fungal Infection 2021 ·Open Forum Infectious Diseases ·John W. Baddley, George R. Thompson, Sharon C.‐A. Chen, P. Lewis White, Melissa D. Johnson, M. Hong Nguyen, Ilan S. Schwartz, Andrej Spec, Luis Ostrosky‐Zeichner, Brendan R. Jackson, Thomas F. Patterson, Peter G. Pappas	82
7	New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies 2019 ·Journal of Fungi ·Thomas F. Patterson, J. Peter Donnelly	43
8	Phase 3 Randomized, Double-Blind Trial Evaluating Isavuconazole vs. Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Spp. or Other Filamentous Fungi (SECURE) 2015 ·Mycoses ·Johan Maertens, Thomas F. Patterson, Galia Rahav, D. P. Kontoyiannis, Kieren A. Marr, (unknown), (unknown), Bernhardt Zeiher, Andrew J. Ullmann	4
9	A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients 2014 ·Thomas F. Patterson	2
10	Prolyl endopeptidase activity in bronchoalveolar lavage fluid: a novel diagnostic biomarker in a guinea pig model of invasive pulmonary aspergillosis 2013 ·Medical Mycology ·(unknown), Douglas S. Watson, Laura K. Najvar, Nathan P. Wiederhold, William R. Kirkpatrick, Thomas F. Patterson, David S. Askew, Krishna Kodukula, Amit K. Galande	6
11	Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis 2011 ·Clinical Microbiology and Infection ·Nathan P. Wiederhold, Laura K. Najvar, Rosie Bocanegra, William R. Kirkpatrick, Thomas F. Patterson	20
12	Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort 2010 ·European Journal of Clinical Microbiology & Infectious Diseases ·J. Hiemenz, Issam Raad, J. Maertens, Ray Hachem, Alfred J. Saah, Carole A. Sable, J Chodakewitz, (unknown), Patricia Saddier, Russell S. Berman, Desmon̄d Ryan, Mark J. DiNubile, Thomas F. Patterson, David W. Denning, Thomas J. Walsh	32
13	Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis 2008 ·Transplant Infectious Disease ·Dimitrios P. Kontoyiannis, V. Ratanatharathorn, Jo‐Anne H. Young, Jane M. Raymond, Michél Laverdière, David W. Denning, Thomas F. Patterson, D. Facklam, Laura Kovanda, (unknown), W. Lau, Donald N. Buell, Kieren A. Marr	75
14	Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign 2007 ·Clinical Infectious Diseases ·Reginald E. Greene, (unknown), J W Oestmann, Paul Stark, Christine M. Durand, Olivier Lortholary, John R. Wingard, Raoul Herbrecht, Patricia Ribaud, Thomas F. Patterson, Peter F. Troke, David W. Denning, John E. Bennett, B.E. de Pauw, R H Rubin	394
15	Disruption of a Nonribosomal Peptide Synthetase in Aspergillus fumigatus Eliminates Gliotoxin Production 2006 ·Eukaryotic Cell ·Robert A. Cramer, Michael P. Gamcsik, (unknown), Laura K. Najvar, William R. Kirkpatrick, Thomas F. Patterson, Carl J. Balibar, John R. Graybill, John R. Perfect, Soman N. Abraham, William J. Steinbach	168
16	Strategy of Following Voriconazole versus Amphotericin B Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies on Outcome 2005 ·Clinical Infectious Diseases ·Thomas F. Patterson, Helen W. Boucher, Raoul Herbrecht, David W. Denning, Olivier Lortholary, Patricia Ribaud, R H Rubin, John R. Wingard, Ben E. dePauw, Haran T. Schlamm, Peter F. Troke, John E. Bennett	65
17	Approaches to fungal diagnosis in transplantation 1999 ·Transplant Infectious Disease ·Thomas F. Patterson	21
18	Cryptococcosis in hiv-infected and non-hiv-infected hosts 1997 ·International Journal of Infectious Diseases ·Thomas F. Patterson	3
19	Cutaneous Cryptococcosis in a Patient with Cutaneous T Cell Lymphoma Receiving Therapy with Photopheresis and Methotrexate 1993 ·Clinical Infectious Diseases ·Thomas R. Frieden, Frank J. Bia, (unknown), R. Eisen, Thomas F. Patterson, Richard L. Edelson	10
20	A NEW SPECIES OF PICEA (PINACEAE) FROM NUEVO LEÓN, MÉXICO 1988 ·Biodiversity Heritage Library (Smithsonian Institution) ·Thomas F. Patterson	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact